Japan stock market week to Jan 12, 2009

19 January 2009

Tokyo retreated in the week to January 12 (four trading days only because the        last day was a national holiday in Japan). The Nikkei  225 was down 2.3%, to close at the 8,800 mark, while the Topix index  fell 2.4%. The market opened higher but suffered a setback towards the  weekend, reflecting profit-taking of export-oriented issues and a dearth  of positive news. Investors continued to anticipate that forthcoming  October-December 2008 quarterly earnings reports of Japanese companies -  to be unveiled later this month - would likely involve some downward  revisions to their full-year guidance due to the impact of the global  economic downturn and the yen's strength. The pharmaceutical index  dropped 4.7%, underperforming the market.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Company News Directory



Companies featured in this story

More ones to watch >






Company Spotlight